Track topics on Twitter Track topics that are important to you
Company’s growth supports upcoming clinical programs to help better predict patient response to oncology drugs before treatment begins KIYATEC, Inc., a privately held...
3D-PREDICT Study to investigate potential impact to outcomes for several difficult-to-treat solid tumors KIYATEC, Inc. today announced the enrollment of the first patie...
SummaryKIYATEC Inc KIYATEC is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It offers drug response p...
KIYATEC is changing the future of cancer care by accurately predicting patient-specific response and non-response to chemotherapy drugs before treatment begins. Wasted time is the...
We have published hundreds of KIYATEC, Inc. news stories on BioPortfolio along with dozens of KIYATEC, Inc. Clinical Trials and PubMed Articles about KIYATEC, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KIYATEC, Inc. Companies in our database. You can also find out about relevant KIYATEC, Inc. Drugs and Medications on this site too.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...